Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lantern Pharma Inc. - Common Stock
(NQ:
LTRN
)
2.645
-0.055 (-2.04%)
Streaming Delayed Price
Updated: 3:13 PM EDT, Mar 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lantern Pharma Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in High-Grade B-cell Lymphomas (HGBL)
November 30, 2023
From
Lantern Pharma Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
November 09, 2023
Via
Benzinga
Lantern Pharma: Q3 Earnings Insights
↗
November 08, 2023
Via
Benzinga
Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights
November 08, 2023
From
Lantern Pharma Inc.
Via
Business Wire
A Preview Of Lantern Pharma's Earnings
↗
November 07, 2023
Via
Benzinga
Lantern Pharma to Report Third Quarter 2023 Operating & Financial Results on November 8th, 2023 at 4:30 p.m. ET
November 01, 2023
From
Lantern Pharma Inc.
Via
Business Wire
The 7 Most Undervalued AI Penny Stocks to Buy: October 2023
↗
October 24, 2023
Unlock exponential growth with the next big undervalued AI penny stocks to buy, offering tremendous upside ahead.
Via
InvestorPlace
Topics
Artificial Intelligence
Lantern Pharma to Present at the ThinkEquity Conference on October 19 at 1:30 p.m. ET
October 10, 2023
From
Lantern Pharma Inc.
Via
Business Wire
Lantern Pharma Announces Publication in Clinical Cancer Research Highlighting the Enhanced Efficacy of LP-184 in Glioblastoma
October 03, 2023
From
Lantern Pharma
Via
Business Wire
Lantern Pharma Announces First Patient Dosed in the Phase 1 Study for LP-184 in Advanced Solid Tumors
September 25, 2023
From
Lantern Pharma Inc.
Via
Business Wire
Lantern Pharma Receives IND Clearance from FDA Enabling Phase 1 Initiation for Drug Candidate LP-284 in Non-Hodgkin’s Lymphomas
September 18, 2023
From
Lantern Pharma Inc.
Via
Business Wire
The 3 Most Undervalued Machine Learning Stocks to Buy in September 2023
↗
September 14, 2023
Here are three machine-learning stocks that may be ready to move much higher when investor sentiment changes.
Via
InvestorPlace
Lantern Pharma to Present Data Highlighting the Anti-Tumor Potency of Drug Candidate LP-284 in Non-Hodgkin’s Lymphomas at the Society of Hematologic Oncology Annual Meeting
August 31, 2023
From
Lantern Pharma Inc.
Via
Business Wire
3 AI Stocks That Still Trade Under $10 Per Share
↗
August 28, 2023
With the artificial intelligence (AI) boom ramping up, check out this short list of hot AI stocks under $10.
Via
InvestorPlace
Topics
Artificial Intelligence
Lantern Pharma Expands AI Capabilities of RADR® Platform to Accelerate the Clinical Development of Immune Checkpoint Inhibitors
August 28, 2023
From
Lantern Pharma Inc.
Via
Business Wire
The 3 Most Undervalued Machine Learning Stocks to Buy Now: August 2023
↗
August 23, 2023
Machine learning stocks still have a lot of room left to rise despite a short-term pullback in their stock prices.
Via
InvestorPlace
8 Best Artificial Intelligence Stocks Under $10
August 18, 2023
If you want to get in on artificial intelligence (AI) but don’t want to spend a lot, why not consider artificial intelligence stocks under $10? Learn more.
Via
MarketBeat
Topics
Artificial Intelligence
Economy
The 3 Most Undervalued AI Penny Stocks to Buy Now: August 2023
↗
August 16, 2023
Not only would I take full advantage of the pullbacks in heavyweight AI stocks, I’d also take advantage of the drops in top AI penny stocks.
Via
InvestorPlace
Topics
Artificial Intelligence
Lantern Pharma Receives Notice of US Patent Allowance for Drug Candidate LP-184 for the Treatment of Rare Pediatric Brain Cancer, ATRT
August 14, 2023
From
Lantern Pharma Inc.
Via
Business Wire
Lantern Pharma Reports Second Quarter 2023 Financial Results and Operational Highlights
August 09, 2023
From
Lantern Pharma Inc.
Via
Business Wire
3 AI Penny Stocks With the Potential to Make Your Financial Dreams Come True
↗
August 09, 2023
These top three AI penny stocks offer immense upside ahead, potentially becoming future market leaders amid a $15.7 trillion projection.
Via
InvestorPlace
3 AI Stocks You’ll Regret Not Buying Soon
↗
August 08, 2023
AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in.
Via
InvestorPlace
7 AI Stocks to Buy Under $5 in August 2023
↗
August 02, 2023
These AI stocks to buy for under $5 in August have strong potential as the sector grows throughout 2023 and beyond.
Via
InvestorPlace
RedChip Launches 'Small Stocks, Big Money' Podcast
August 02, 2023
Via
ACCESSWIRE
Lantern Pharma to Report Second Quarter 2023 Operating & Financial Results on August 9, 2023 at 4:30 p.m. ET
August 02, 2023
From
Lantern Pharma Inc.
Via
Business Wire
3 AI Stocks to Buy Under $10 in August 2023
↗
August 01, 2023
The bull market in artificial intelligence is just getting started, creating big opportunity for this list of AI stocks under $10.
Via
InvestorPlace
7 AI Penny Stocks that Could Hit $5 Soon
↗
July 30, 2023
Here are seven AI penny stocks with huge potential as you look to make life-changing money from the advance of artificial intelligence.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
July 18, 2023
Via
Benzinga
Lantern Pharma to Participate and Present at Multiple Upcoming Conferences
July 17, 2023
From
Lantern Pharma Inc.
Via
Business Wire
Oncotarget Publishes New Data by Lantern Pharma, an AI Company Developing Cancer Therapies, Further Supporting Clinical Advancement of LP-284, a Novel Synthetically Lethal Drug Candidate for Non-Hodgkin’s Lymphomas
June 26, 2023
From
Lantern Pharma Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
